Live
Will the FDA approve retatrutide? — retatrutide (LY3437943)
Starts:May 14, 2026, 2:00 AMEnds:Jan 1, 2029, 4:59 AM
AZRGMIKSHLMTNVGPLYPMU
Total volume
$50.4K
Largest spread
—
Outcomes
5
Platforms
1
Markets
1
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Volume | Azuro | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|---|---|
Before Jan 1, 2028 Favorite | 86.0%Kalshi | $3.1K | — | — | — | — | — | — | |
Before Jul 1, 2027 | 33.0%Kalshi | $15.5K | — | — | — | — | — | — | |
Before Jan 1, 2027 | 4.0%Kalshi | $31.6K | — | — | — | — | — | — | |
Before Jan 1, 2028Favorite
86.0%Best · Kalshi$3.1K
Before Jul 1, 2027
33.0%Best · Kalshi$15.5K
Before Jan 1, 2027
4.0%Best · Kalshi$31.6K
AI-generated summary, may be inaccurate.
A detailed summary of this event hasn't been generated yet. Once available, it will explain the context, key contenders, and what each outcome resolves to.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.